Teri Rosenbaum-Chou, PhD
A founding team member of modus health, Teri became CEO of modus health in December 2017. She previously served as modus health’s Chief Scientific Officer and was instrumental in obtaining the funding and leading the produc
Board of Directors
Peter joined Schooner Capital in 2008 as a Managing Director after almost ten years with management consultancy McKinsey & Company. While there, Peter specialized in corporate finance and strategy, advising leading players in the consumer packaged goods and retail industries in the US, Latin America, and Western Europe. Core areas of focus included mergers and acquisitions, new market entry and growth strategies, competitive strategy, post-merger integration, and operational effectiveness. At Schooner, Peter serves as a director on the boards of RailComm, Colo Railroad Builders, Orthocare Innovations, and CustomMade. He also provides strategic and corporate finance support across the full portfolio. Peter holds a JD/MBA from Harvard Law and from Harvard Business School where he was a Baker scholar, and an AB with Honors from Harvard University where he graduated Phi Beta Kappa in Economics and Social Studies.
David Boone, PhD, MPH, CP
David Boone, Co-founder, Chief Technology Officer and President of Orthocare Innovations, has spent the past twenty years as an innovator, developer, researcher, and instructor in rehabilitation and bioengineering. A frequent lecturer at academic medical centers on a range of prosthetic and rehabilitation topics and a widely published author, he is credited with multiple technology patents, including a foot scanning technology that was licensed to Nike. He also was the principal developer of a range of innovative lower limb prosthetics products and technologies that were sold and/or licensed via Orthocare’s partnership with Ottobock, a global medical device company based in Germany.
David received his PhD in Bioengineering from The Hong Kong Polytechnic University and became one of fewer than ten American PhDs with formal training and clinical experience in prosthetics. He began his work in in the field under the direction of a pioneer in the field, Dr. Ernest Burgess, and later assumed leadership of Dr. Burgess’ lab, Prosthetic Research Study (PRS) in Seattle. It was in this capacity that he led the development team that created the StepWatch technology. David was recently named Editor-in-Chief of the Journal of Prosthetics and Orthotics by the American Academy of Orthotists and Prosthetists.
Ted has been a Managing Director at Schooner Capital since 2004. Along with his colleagues, Ted invests across asset classes, domestically and abroad, with particular interest in domestic venture and growth stage companies, as well as alternative asset holdings in developing markets. Presently, Ted serves as a director at Orthocare Innovations, MediaSilo, Millstone Medical Outsourcing, Nanoscale Powders, Seventh Generation, SRS Medical, Topokine Therapeutics, and Zixi. At Millstone Medical Outsourcing and Zixi, he serves as chairman. He is a past director of a number of Schooner investments, as well as several not-for-profit organizations. Prior to joining Schooner, Ted founded several enterprises in the for-profit education sector, served as a general manager at subsidiaries of The Washington Post Company, worked in venture capital at Fidelity Capital, and served global clients at Leo Burnett. Ted received an MBA from Harvard Business School and is a cum laude graduate of Dartmouth College, with a degree in Chinese language and culture.
Doug co-founded modus health and Orthocare Innovations, a company where he served as CEO from inception through completion of a significant transaction with a strategic partner and global player in the field, Ottobock. Prior to focusing on building early stage companies, Doug spent sixteen years working at the intersection of politics, policy, law, and business advising organizations and corporations, ranging from early stage medical technology companies to large health systems, achieve strategic growth objectives. A recognized Washington, D.C. advocate and strategist, Doug was a partner in the international law firm of Sonnenschein, Nath & Rosenthal, practicing as a public policy and health care lawyer in the firm’s Washington office. Prior to this position he was an associate at the Washington, D.C. firm Arent Fox and Vice President at the federal consulting subsidiary of Baker and Daniels. Doug received his BA from the University of Southern California, and earned his JD from the American University Washington College of Law. He recently completed a five-year term on the Defense Health Board as an appointee of the U.S. Secretary of Defense.
Scientific Advisory Board
Lee Dibble, PhD, PT, ATC
Dr. Dibble received his master’s degree in physical therapy from Duke University in 1991 and his doctoral degree in exercise and sport science from the University of Utah in 2001. He is currently an Associate Professor within the Department of Physical Therapy from the University of Utah, Director of Parkinsonism Exercise Program, and Co-director of the motion analysis core facility. Dr. Dibble’s research focuses on the effect of Parkinson disease on postural control and falls, as well as the effect of exercise countermeasures as a means of minimizing these deficits. Through his participation as PI or co-investigator on previous and current grants, Dr. Dibble has developed the expertise in cross sectional studies, implementation of clinical trials of rehabilitative interventions, and longitudinal studies of the progression of disability. Dr. Dibble’s three long-term objectives are: 1) Characterize the benefits of exercise in neurodegenerative diseases in terms of central nervous system effect and alteration of the trajectory of disability. 2) Understand anticipatory and reactive postural control deficits in persons with neurodegenerative diseases. 3) Explore treatments targeted at augmenting sensory input, normalizing sensory integration, and improving motor output during postural reactions.
Andrew Gardner, PhD
Dr. Gardner received his doctoral degree in Exercise Science from Arizona State University in 1990. Currently, Dr. Gardner is a Professor within the College of Medicine/Department of Geriatrics and the Donald W. Reynolds Chair of Aging Research. As an exercise physiologist with expertise in exercise rehabilitation and physiology related peripheral artery disease (PAD) and aging, Dr. Gardner has published high-impact studies that have focused on: (1) validating a treadmill exercise protocol to assess primary outcome measures used in many clinical trials world-wide, (2) randomized controlled clinical trials demonstrating the efficacy of supervised exercise programs to improve ambulatory function in patients with PAD and intermittent claudication, and (3) a recent randomized controlled clinical trial demonstrating the efficacy of a home-based exercise program to treat intermittent claudication. In addition to his interest in PAD, Dr. Gardner studies the effects of co-morbid conditions and cardiovascular risk factors, such as metabolic syndrome, age and smoking on vascular function, physical activity and function and metabolic function in older adults. This work has led to more than 135 peer-reviewed clinical research publications.
Dr. Gardner’s role at the Reynolds Oklahoma Center on Aging (ROCA) is to bridge the basic science research efforts of other faculty members in ROCA with clinical studies and the clinical research activities within the Department of Geriatric Medicine. Dr. Gardner has established a collaborative network of vascular medicine specialists, cardiologists, and physicians at the University of Oklahoma Health Sciences campus and at the Oklahoma City VA Medical Center to provide a referral base of patients with PAD and other vascular diseases. His research team is experienced in successfully recruiting patients, administering clinical research tests, conducting interventions, and retaining patients in randomized controlled trials. Additional collaborations include clinical and translational studies in patients with vascular-mediated dementia and cognitive impairment. Finally, the roles of vascular function, oxidative stress and inflammation with muscle function, gait, balance, and falls in older adults are a developing clinical and translational research approach that merges clinical faculty in the Department of Geriatric Medicine with basic scientists within the department.
George Fulk, PhD, PT
Dr. Fulk received his master’s degree in physical therapy from the University of Massachusetts and his doctoral degree in physical therapy from Nova Southeastern University in 2005. Dr. Fulk’s research projects have primarily focused on measuring and improving locomotor capability in people with stroke. Specifically, his research has looked at methods of measuring walking ability and overall participation in people with stroke, interventions to improve walking ability in people with stroke and other neurological conditions, and the development and use of rehabilitation engineering technologies to enhance recovery in people with neurological disorders. He has collaborated with engineering faculty to develop novel technologies that monitor walking activity and ambulatory assistive devices.
Thomas George Hornby, PhD, PT
Dr. Hornby received his doctoral degree in Physiological Sciences from the University of Arizona. He is a Research Assistant Professor at Northwestern University and Director of the Locomotor Recovery Laboratory at the Rehabilitation Institute of Chicago.
Dr. Hornby’s primary interests include improving locomotor function in individuals who have experienced motor impairments due to stroke or spinal cord injury (SCI). His research is integrative in that he focuses on new discoveries and on translation of these findings into rehabilitative protocols that can be implemented in the clinic. Past work has investigated the mechanisms underlying behavioral changes due to the use of robotics, body-weight-supported treadmill training, and pharmacologic agents, as well as their clinical efficacy. Current research activities include looking at the acute and chronic effects of intensive locomotor training on endogenous neurotrophins that promote synaptic connectivity; electrophysiological studies of neural mechanisms underlying volitional force generation; pharmacological studies of various drugs and their effects on motor control; and interventional studies that employ task variability and high intensity training in order to maximize recovery of stepping activity in neurologically impaired individuals.